A record £3.5 billion was spent by the British pharmaceutical industry in 2003 in the search for new medicines

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret   Woods Kent  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Sales for Krka and Lek, the two largest pharmaceutical companies in Slovenia, rose by 10.2% and 51.9% in 2003 to reach Tol97 billion and Tol145 billion, respectively

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain

By Darba J.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1211-1212

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics in the New Millennium: A Pharmaceutical Industry Perspective

By Thwaites R.  

PharmacoEconomics, Vol. 13, Iss. 2, 1998-02 ,pp. : 175-180

Adis International

Access to resources Recommend Favorite